Lumos Diagnostics Holdings Ltd (LDX) — Capital Reinvestment Ratio

Latest as of December 2025: 0.24x

Lumos Diagnostics Holdings Ltd (LDX) has a Capital Reinvestment Ratio of 0.24x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$778.03K) in capital expenditures (AU$189.41K). See LDX equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

AU$778.03K
AUD

Capital Expenditures

AU$189.41K
AUD

Data as of

Dec 2025
Most recent filing

Lumos Diagnostics Holdings Ltd Capital Reinvestment Ratio (2023–2023)

This chart tracks Lumos Diagnostics Holdings Ltd's Capital Reinvestment Ratio across 1 annual periods. Check LDX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Lumos Diagnostics Holdings Ltd (2023–2023)

Year-by-year Capital Reinvestment Ratio for Lumos Diagnostics Holdings Ltd from 2023 to 2023. For live market cap and broader valuation context, see LDX company net worth.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2023 0.10x AU$946.00K AU$98.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow